المؤلفون: Kaftantzi, Lamprini V.

مصطلحات موضوعية: 610.28

الإتاحة: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.645938Test

المؤلفون: Langford, Thomas, Arkir, Zehra, Chalkidou, Anastasia, Goddard, Kate, Kaftantzi, Lamprini, Samaan, Mark, Irving, Peter

المصدر: Langford , T , Arkir , Z , Chalkidou , A , Goddard , K , Kaftantzi , L , Samaan , M & Irving , P 2018 , ' The Clinical and Cost-Effectiveness of 4 Enzyme-Linked Immunosorbent Assay Kits for Monitoring Infliximab in Crohn Disease Patients : Protocol for a Validation Study ' , JMIR research protocols , vol. 7 , no. 10 , e11218 . https://doi.org/10.2196/11218Test

مصطلحات موضوعية: Anti-TNF, Antidrug antibodies, Crohn’s disease, ELISA, Inflammatory bowel disease, Infliximab, Therapeutic drug monitoring

الإتاحة: https://doi.org/10.2196/11218Test
https://kclpure.kcl.ac.uk/portal/en/publications/da913e35-9410-407e-8b94-10d74230cbffTest
http://www.scopus.com/inward/record.url?scp=85102368064&partnerID=8YFLogxKTest

المؤلفون: Langford, Thomas Richard Daniel, Arkir, Zehra, Chalkidou, Anastasia, Goddard, Kate, Kaftantzi, Lamprini, Samaan, Mark Alphonse, Irving, Peter

المصدر: Langford , T R D , Arkir , Z , Chalkidou , A , Goddard , K , Kaftantzi , L , Samaan , M A & Irving , P 2018 , ' Investigating the clinical and cost effectiveness of 4 ELISA kits for monitoring infliximab in patients with Crohn’s disease : Protocol for a validation study ' , JMIR research protocols .

الإتاحة: https://kclpure.kcl.ac.uk/portal/en/publications/investigating-the-clinical-and-cost-effectiveness-of-4-elisa-kits-for-monitoring-infliximab-in-patients-with-crohns-diseaseTest(3912063e-44b4-4ced-819d-cb96f7408d61).html

المؤلفون: Langford, Thomas, Arkir, Zehra, Chalkidou, Anastasia, Goddard, Kate, Kaftantzi, Lamprini, Samaan, Mark, Irving, Peter

المصدر: JMIR Research Protocols

مصطلحات موضوعية: Crohn’s disease, medicine.medical_specialty, Cost effectiveness, therapeutic drug monitoring, Disease, Inflammatory bowel disease, 03 medical and health sciences, 0302 clinical medicine, Quality of life (healthcare), inflammatory bowel disease, Protocol, medicine, antidrug antibodies, 030212 general & internal medicine, Intensive care medicine, Protocol (science), Crohn's disease, medicine.diagnostic_test, business.industry, anti-TNF, General Medicine, medicine.disease, Infliximab, 3. Good health, Therapeutic drug monitoring, ELISA, 030211 gastroenterology & hepatology, infliximab, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fec5304268af32ac8b8dfcdbac0ca896Test
https://doi.org/10.2196/11218Test

المؤلفون: Franklin, Sarah, Kaftantzi, Lamprini

المصدر: Science as Culture ; volume 17, issue 4, page 449-462 ; ISSN 0950-5431 1470-1189

الإتاحة: https://doi.org/10.1080/09505430802515270Test

المؤلفون: Kaftantzi, Lamprini V

المصدر: IndraStra Global.

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=issn23813652::e846dd537b4bfca9a9494d3f75505875Test
https://igi.indrastra.com/items/show/299806Test

المؤلفون: Langford, Thomas, Arkir, Zehra, Chalkidou, Anastasia, Goddard, Kate, Kaftantzi, Lamprini, Samaan, Mark, Irving, Peter

المصدر: Journal of Medical Internet Research; Oct2018, Vol. 20 Issue 10, p142-142, 1p

مصطلحات موضوعية: CROHN'S disease, ENZYME-linked immunosorbent assay, INFLAMMATORY bowel diseases, SOLID-phase analysis, INFLIXIMAB